serine/threonine Kinase 17b (STK17B) (C-Term) Peptide
STK17B
Reactivité: Humain
BP
Sodium azide
N° du produit ABIN1382031
-
-
Antigène
Tous les produits DRAK2 (STK17B)
-
DRAK2 (STK17B)
(serine/threonine Kinase 17b (STK17B))
-
Protein Region
-
C-Term
-
Origine
-
Humain
-
Application
-
Blocking Peptide (BP)
-
Attributs du produit
-
15 amino acids near the carboxy terminus of human DRAK2.
Human
-
-
-
Indications d'application
-
DRAK2 peptide is used for blocking the activity of DRAK2.
-
Restrictions
-
For Research Use only
-
-
Format
-
Liquid
-
Concentration
-
200 μg/mL
-
Buffer
-
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
-
Agent conservateur
-
Sodium azide
-
Précaution d'utilisation
-
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
-
-20 °C
-
Date de péremption
-
12 months
-
-
Antigène
-
DRAK2 (STK17B)
(serine/threonine Kinase 17b (STK17B))
-
Synonymes
-
zgc:65989 Peptide, STK17B Peptide, DRAK2 Peptide, Drak2 Peptide, 3110009A03Rik Peptide, AI120141 Peptide, serine/threonine kinase 17b (apoptosis-inducing) Peptide, serine/threonine kinase 17b Peptide, stk17b Peptide, STK17B Peptide, Stk17b Peptide
-